Hemp compounds identified by Oregon State University research via a chemical screening technique invented at OSU show the ability to prevent the virus that causes COVID-19 from entering human cells.
Jan 11, 2022
0
3157
Detection of circulating tumor cells (CTCs) in the blood of cancer patients is of intense interest to medical oncologists. The promise of being able to detect such rare cells consistently and reproducibly has attracted considerable ...
Dec 9, 2021
0
1
Controlling signal transmission and reception within the brain circuits is necessary for neuroscientists to achieve a better understanding of the brain's functions. Communication among neuron and glial cells is mediated by ...
Nov 30, 2021
0
3
Imagine you could cure cancer by targeting one tiny gene. Imagine that same gene occurred in every major cancer, including breast, prostate, lung, liver and colon. Imagine that the gene is not essential for healthy activity, ...
Nov 30, 2021
1
493
Doctors and scientists from the German Cancer Research Center (DKFZ) and from Heidelberg University's Medical Faculty Mannheim have successfully tested a neoantigen-specific transgenic immune cell therapy for malignant brain ...
Nov 15, 2021
0
12
A new batch of prognostic cancer biomarkers have been discovered in an area where few have gone looking before. Researchers have unveiled a catalog of 166 prognostic biomarkers, generated by analyzing long non-coding RNAs ...
Nov 15, 2021
0
54
Researchers have made a huge leap forward in finding a targeted therapy for acute myeloid leukemia.
Nov 10, 2021
0
116
Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of German, Norwegian and British scientists who analyzed tumor cells that proved resistant to the original treatment. ...
Oct 25, 2021
0
8
Researchers at the Technion—Israel Institute of Technology have developed an innovative treatment for breast cancer, based on analgesic nanoparticles that target the nervous system. The study, published in Science Advances, ...
Oct 18, 2021
0
98
A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual ...
Oct 7, 2021
0
1
